Beruflich Dokumente
Kultur Dokumente
28, 2003
Name: S.I.D.
Question 1
The figure on the right shows a diagrammatic representation of the lambda ZAP vector.
During the excision process, XL1-Blue MRF’ and SOLR are employed as the first and
second bacterial hosts, respectively.
1
BIO4320 Molecular Biology & Genetic Engineering Oct. 28, 2003
Name: S.I.D.
No products
(a) Based on the results shown in the figure on the right,
propose a possible function of DMSO (1 mark)
DMSO may help to reduce the annealing at G-C rich
regions and hence allows better PCR.
2
BIO4320 Molecular Biology & Genetic Engineering Oct. 28, 2003
Name: S.I.D.
Question 3
A patient is infected by a pathogenic bacterium. There are two subtypes of this
bacterium: strain A and strain B. For proper treatments, the doctor needs to check whether
the patient is infected by strain A or strain B.
The genome of strain A is identical to that of strain B except the presence of a 40-bp
region in strain A.
Design a strategy to diagnose whether the patient is infected by strain A or strain B. Use
diagrams whenever appropriate (7 marks)
3
BIO4320 Molecular Biology & Genetic Engineering Oct. 28, 2003
Name: S.I.D.
Question 4
The same sample from Question 3 was sent to a different laboratory. In this laboratory,
only heat stable DNA polymerase but not heat stable DNA ligase is available. Also, this
laboratory only has reagents for running an agarose gel (i.e. NOT able to separate DNA
molecules of small molecular weight). Other reagents and facilities are the same as that in
Question 1. You can synthesize more primers if needed. Design a strategy to perform the
diagnosis in this laboratory. (3 marks)
Remarks: if use two primers flanking the 40-bp region, give 1 mark only (since the
differences resulting from strain A and strain B cannot be seen using agarose gel.
4
BIO4320 Molecular Biology & Genetic Engineering Oct. 28, 2003
Name: S.I.D.
Question 5
A new 5’-RACE method was invented to specifically target full-length mRNAs. In
eukaryotes, each mRNA contains a poly A tail at the 3’ end as well as a G-cap (m7G-p-p-p) at
the 5’end. A truncated mRNA does not contain a G-cap, but ended with a 5’ phosphate
group (p).
(i) CIP (calf intestinal phosphatase): removes 5’ phosphate but not G-cap;
(ii) TAP (pyrophosphatase): removes G-cap to expose the 5’ phosphate group;
(iii) RNA ligase: ligate the 3’-OH group of a RNA molecule to the 5’ phosphate group of a
RNA molecule.
(a) Draw a flow chart to illustrate the sequence of event leading to the addition of the RNA
oligo to the 5’ end of only full-length but not truncated mRNA molecules). (6 marks)
(1) Add CIP to remove 5’ phosphate groups from truncated mRNA (1);
(2) Add TAP to remove G-cap (1) and expose 5’ phosphate groups from full-length mRNAs
(1);
(3) Add RNA oligo and RNA ligase (1);
(4) RNA oligo will only ligate to full-length mRNAs but not truncated mRNAs (1) because
truncated mRNAs do not 5’ phosphate groups (1);
(b) Propose the subsequent steps for this enhanced 5’-RACE. (Do not forget that you now
have an additional known sequence added to the 5’ end of mRNAs.) (4 marks)
- END -